Brown Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,538
Closed -$327K 126
2022
Q1
$327K Buy
4,538
+120
+3% +$8.64K ﹤0.01% 117
2021
Q4
$406K Hold
4,418
﹤0.01% 116
2021
Q3
$560K Hold
4,418
﹤0.01% 107
2021
Q2
$735K Buy
4,418
+361
+9% +$58.5K 0.01% 99
2021
Q1
$737K Buy
4,057
+1,745
+75% +$405K 0.01% 101
2020
Q4
$462K Buy
2,312
+88
+4% +$17.9K ﹤0.01% 107
2020
Q3
$488K Buy
2,224
+4
+0.2% +$847 ﹤0.01% 99
2020
Q2
$424K Hold
2,220
﹤0.01% 103
2020
Q1
$344K Buy
+2,220
New +$258K ﹤0.01% 102

Other funds holding TDOC

Brown Capital Management's TDOC Position: Q2 2022 in Review

Brown Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,538 shares — an estimated $327K sold.

Brown Capital Management first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $737K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Brown Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Brown Capital Management sold 4,538 Teladoc Health shares in Q2 2022, an estimated $327K.
  • Brown Capital Management first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Brown Capital Management's Teladoc Health position peaked at $737K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Brown Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.